ATE463509T1 - Stabilisierung von herz-troponin - Google Patents

Stabilisierung von herz-troponin

Info

Publication number
ATE463509T1
ATE463509T1 AT06750874T AT06750874T ATE463509T1 AT E463509 T1 ATE463509 T1 AT E463509T1 AT 06750874 T AT06750874 T AT 06750874T AT 06750874 T AT06750874 T AT 06750874T AT E463509 T1 ATE463509 T1 AT E463509T1
Authority
AT
Austria
Prior art keywords
troponin
proteins
complex
stabilized
stabilization
Prior art date
Application number
AT06750874T
Other languages
English (en)
Inventor
Don Laird
Charles Young
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE463509T1 publication Critical patent/ATE463509T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06750874T 2005-04-28 2006-04-20 Stabilisierung von herz-troponin ATE463509T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67554205P 2005-04-28 2005-04-28
PCT/US2006/014958 WO2006116005A2 (en) 2005-04-28 2006-04-20 Stabilization of cardiac troponin

Publications (1)

Publication Number Publication Date
ATE463509T1 true ATE463509T1 (de) 2010-04-15

Family

ID=37027832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06750874T ATE463509T1 (de) 2005-04-28 2006-04-20 Stabilisierung von herz-troponin

Country Status (8)

Country Link
US (1) US20070082410A1 (de)
EP (1) EP1877432B1 (de)
JP (1) JP2008539434A (de)
AT (1) ATE463509T1 (de)
CA (1) CA2606333A1 (de)
DE (1) DE602006013443D1 (de)
ES (1) ES2342104T3 (de)
WO (1) WO2006116005A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018051965A1 (ja) 2016-09-13 2018-03-22 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
JP7750608B2 (ja) * 2020-07-10 2025-10-07 積水メディカル株式会社 Ｔａｒｃを含有する組成物、及びｔａｒｃの保存安定性向上方法
WO2026009767A1 (ja) * 2024-07-05 2026-01-08 富士レビオ株式会社 Ｇｆａｐ含有組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130280C (en) * 1993-08-24 1999-08-31 Lilian Lee Method for purification of cardiac troponin i
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
FR2734267B1 (fr) * 1995-05-16 1997-08-01 Pasteur Sanofi Diagnostics Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee
DE19524572A1 (de) * 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
EP1000140A1 (de) * 1997-06-13 2000-05-17 Medical Analysis Systems, Inc. (MAS) Stabilisierte herz-marker-zusammensetzungen
KR100508695B1 (ko) * 2001-02-13 2005-08-17 한국과학기술연구원 인슐린의 경구투여용 제형과 그의 제조방법
US6538104B2 (en) * 2001-04-27 2003-03-25 Medical Analysis Systems, Inc. Stabilization of cardiac troponin I subunits and complexes
US20040022792A1 (en) * 2002-06-17 2004-02-05 Ralph Klinke Method of stabilizing proteins at low pH
US20050136542A1 (en) * 2003-12-19 2005-06-23 Beckman Coulter, Inc. Stabilized liquid reference solutions

Also Published As

Publication number Publication date
JP2008539434A (ja) 2008-11-13
EP1877432A2 (de) 2008-01-16
CA2606333A1 (en) 2006-11-02
EP1877432B1 (de) 2010-04-07
US20070082410A1 (en) 2007-04-12
DE602006013443D1 (de) 2010-05-20
WO2006116005A2 (en) 2006-11-02
WO2006116005A3 (en) 2007-02-15
ES2342104T3 (es) 2010-07-01

Similar Documents

Publication Publication Date Title
ES2391613T3 (es) Un procedimiento para purificar el factor de coagulación VIII
HENSCHEN‐EDMAN Fibrinogen non‐inherited heterogeneity and its relationship to function in health and disease
Frith et al. The pathophysiology of trauma-induced coagulopathy
Ryan et al. Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology
EA200501675A1 (ru) Фармацевтическая композиция, содержащая лактат, и ее применение
WO2004017895A3 (en) Formaldehyde-ammonium salt complexes for the stabilization of blood cells
CY1112797T1 (el) Συμπλοκο σκληροστινης και νογκινης ή χορδινης, και παραγοντες που ρυθμιζουν το σχηματισμο του εν λογω συμπλοκου
DE60135498D1 (de) Produktion von ganzen Antikörpern in prokaryontischen Zellen
EP1436617A4 (de) Patientenklassifizierung
DE60236605D1 (de) Zusammensetzungen und deren verwendung zur behandlung von krebs
DE60024669D1 (de) Hämatologische bestimmung und reagenz
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
NO20076475L (no) Enkeltdomene VHH antilegemer mot Van Willebrand faktor
ATE412774T1 (de) Parallele genotypisierung mehrerer patientenproben
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
ATE463512T1 (de) Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
WO2002063271A8 (en) Activity based probe analysis
ATE458816T1 (de) Fluoreszierendes protein aus aequorea coerulescens und ihre verwendungen
DK0458937T3 (da) Varianter af PAI-2
NO20052992L (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
ATE463509T1 (de) Stabilisierung von herz-troponin
DE60140707D1 (de) GSK3-Polypeptide
de Almeida et al. Erythrocyte deformability dependence on band 3 protein in an in-vitro model of hyperfibrinogenemia
Nishi et al. Interaction of Aripiprazole With Human α1-Acid Glycoprotein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties